Scientists uncover a promising strategy to combat leukaemia resistance
18th May 2023
Research reveals a vulnerability in leukaemia cells that causes them to fill with toxic fatty acids
Read more
Ovarian cancer’s protective barrier: how the tumour matrix teaches cells to disarm immune attack
15th May 2023
The results suggest new strategies to overcome the cancer’s defences and treat patients more effectively
Read more
Welcoming Professor Francesca Ciccarelli to the BCI
24th April 2023
Professor Francesca Ciccarelli will be joining Barts Cancer Institute to lead our Centre for Cancer Genomics & Computational Biology.
Read more
Clinical trial shows tumour-starving drug improves survival of mesothelioma
16th April 2023
An innovative therapy provides new hope to patients with malignant mesothelioma – a rare but rapidly fatal type of cancer with few effective treatment options – according to results presented by Professor Peter Szlosarek and his team at Barts Cancer Institute, Queen Mary University of London.
Read more
Vitamin B5 could improve red blood cell production in people with myelodysplastic syndromes
2nd March 2023
Scientists from Barts Cancer Institute at Queen Mary University of London and the Francis Crick Institute, have uncovered why patients with a rare type of blood cancer suffer from ineffective red blood cell production, and how vitamin B5 could be combined with existing drugs to improve outcomes.
Read more
UK charities join forces to fund the work of Dr Angus Cameron
5th April 2018
BCI’s Dr Angus Cameron, Centre for Tumour Biology, is to receive joint funding from Worldwide Cancer Research and Pancreatic Cancer Research Fund (PCRF) to support vital research on pancreatic cancer. The charities have awarded equal sums totalling £235,000 to support the work of Dr Cameron and his laboratory group.
Read more